Trial intelligence / Profile preview

Metformin for portal hypertension in cirrhosis

2017-001132-19Phase 4Completed

Sponsor
Aarhus University Hospital
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Cirrhosis and Portal Hypertension (PH) comparing Metformin with Placebo (2 arms). Primary endpoint: Change in portal pressure during liver vein catheterization. Started Apr 2017; status: completed.

02

Drugs

metformin
03

Conditions

CirrhosisPortal Hypertension (PH)

Beyond the preview

Go deeper on 2017-001132-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001132-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call